Kaival Brands Innovations (KAVL) 10-K 15 Feb 22 2021 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Oct. 31, 2021	Feb. 11, 2022	Apr. 30, 2021
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2021
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--10-31
Entity File Number	000-56016
Entity Registrant Name	Kaival Brands Innovations Group, Inc.
Entity Central Index Key	0001762239
Entity Tax Identification Number	83-3492907
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	4460 Old Dixie Highway
Entity Address, City or Town	Grant
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32949
City Area Code	833
Local Phone Number	452-4825
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	KAVL
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 99,686,691
Entity Common Stock, Shares Outstanding		30,233,319

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($)	Oct. 31, 2021	Oct. 31, 2020
CURRENT ASSETS:
Cash	$ 7,760,228	$ 7,421,701
Restricted cash	65,007
Accounts receivable	1,985,186	1,401,562
Accounts receivable – related parties		15,360
Inventory deposit – related party	2,925,000
Inventories	15,326,370	6,383
Prepaid expenses	319,531
Income tax receivable	1,753,594
Total current assets	30,134,916	8,845,006
Right of use asset- operating lease	55,604	70,133
TOTAL ASSETS	30,190,520	8,915,139
CURRENT LIABILITIES:
Accounts payable	242,829
Accounts payable- related party	12,667,769	1,409,561
Accrued expenses	579,604	1,062,105
Income tax accrual		1,331,856
Deferred revenue		623,096
Operating lease obligation, short term	13,020	11,709
Customer refund due	316,800
Total current liabilities	13,820,022	4,438,327
LONG TERM LIABILITIES
Operating lease obligation, net of current portion	46,185	59,204
TOTAL LIABILITIES	13,866,207	4,497,531
STOCKHOLDERS’ EQUITY:
Preferred stock 5,000,000 shares authorized; Series A Convertible Preferred stock ($0.001 par value, 3,000,000 shares authorized , 3,000,000 shares issued and outstanding as of October 31, 2021 and October 31, 2020, respectively)	3,000	3,000
Common stock ($0.001 par value, 1,000,000,000 shares authorized, 30,195,312 and 23,106,886 issued and outstanding as of October 31, 2021 and October 31, 2020, respectively)	30,195	23,107
Additional paid-in capital	21,551,959	618,904
Retained earnings (accumulated deficit)	(5,260,841)	3,772,597
Total Stockholders’ Equity	16,324,313	4,417,608
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	$ 30,190,520	$ 8,915,139

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical) - $ / shares	Oct. 31, 2021	Oct. 31, 2020
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	30,195,312	23,106,886
Common stock, shares outstanding	30,195,312	23,106,886
Series A Preferred Stock [Member]
Preferred stock, shares authorized	3,000,000	3,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	3,000,000	3,000,000
Preferred stock, shares outsanding	3,000,000	3,000,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Revenues
Revenues, net	$ 59,378,208	$ 64,742,721
Revenues - related parties	154,560	233,955
Excise tax on products	(756,338)	(662,297)
Total revenues, net	58,776,430	64,314,379
Cost of revenue
Cost of revenue - related party	46,528,501	53,981,351
Cost of revenue – other	314,049	273,885
Total cost of revenue	46,842,550	54,255,236
Gross profit	11,933,880	10,059,143
Operating expenses
Advertising and promotions	3,195,883	2,343,617
General & Administrative expenses	19,207,028	2,355,971
Total operating expenses	22,402,911	4,699,588
Other income
Interest income	395	1,048
Total other income	395	1,048
Income (loss) before income taxes provision	(10,468,636)	5,360,603
Provision (benefit) for income taxes	(1,435,198)	1,514,781
Net income (loss)	$ (9,033,438)	$ 3,845,822
Net income (loss) per common share - basic and diluted	$ (0.38)	$ 0.09
Weighted average number of common shares outstanding - basic and diluted	24,000,246	43,017,745

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balances, October 31, 2020 at Oct. 31, 2019		$ 47,697	$ (19,358)	$ (73,225)	$ (44,886)
Balance at beginning (in shares) at Oct. 31, 2019		47,697,048
Common stock issued for employee compensation		$ 110	158,150		158,260
Common stock issued for employee compensation, shares		110,000
Common stock issued for compensation		$ 319	610,858		611,177
Common stock issued for compensation, shares		318,671
Balances, October 31, 2021 at Oct. 31, 2020	3,000	$ 23,107	618,904	3,772,597	4,417,608
Common stock settled and canceled		$ (19)	(179,903)		(179,922)
Balance at end (in shares) at Oct. 31, 2020	3,000,000	23,106,886
Common stock settled and cancelled, shares		(18,833)
Return of common stock in exchange for Series A convertible preferred stock	$ 3,000	$ (25,000)	22,000
Return of common shares in exchange for Series A convertible preferred shares (in shares)	3,000,000
Return of common stock in exchange for Series A convertible preferred stock, shares		(25,000,000)
Expenses paid on behalf of the Company and contributed to capital			27,157		27,157
Net loss				3,845,822	3,845,822
Common stock issued for employee compensation		$ 221	505,100		505,321
Common stock issued for employee compensation, shares		221,666
Stock option expense			1,773,947		1,773,947
Common stock issued for cash, net of financing cost		$ 5,405	8,300,367		8,305,772
Common stock issued for cash, net of financing cost, shares		5,405,000
Common stock issued for warrant exercise		$ 880	1,664,233		1,665,113
Common stock issued for warrant exercise, shares		879,828
Common stock issued for compensation		$ 675	8,943,425		8,944,100
Common stock issued for compensation, shares		674,803
Balances, October 31, 2021 at Oct. 31, 2021	3,000	$ 30,195	21,551,959	(5,260,841)	16,324,313
Common stock settled and canceled		$ (93)	(254,017)		(254,110)
Balance at end (in shares) at Oct. 31, 2021	3,000,000	30,195,312
Common stock settled and cancelled, shares		(92,871)
Net loss				$ (9,033,438)	$ (9,033,438)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (9,033,438)	$ 3,845,822
Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities:
Stock based compensation	9,449,421	769,437
Stock option expense	1,773,947
ROU operating lease expense	14,529	3,616
Expenses contributed to capital		27,157
(Changes in current assets and liabilities:
Accounts receivable	(583,624)	(1,401,562)
Accounts receivable – related parties	15,360	(15,360)
Prepaid expenses	(319,531)
Inventory	(15,319,987)	(6,383)
Inventory deposit – related party	(2,925,000)
Income tax receivable	(1,753,594)
Accounts payable	242,829
Accounts payable – related party	11,258,208	1,409,561
Accrued expenses	(482,501)	1,017,219
Deferred revenue	(623,096)	623,096
Income tax accrual	(1,331,856)	1,331,856
Customer refund due	316,800
Payments on operating lease obligation	(11,708)	(2,836)
Net cash (used in) provided by operating activities	(9,313,241)	7,601,623
CASH FLOWS FROM FINANCING ACTIVITIES:
Common stock issued for cash, net of financing cost	8,305,772
Proceeds from the exercise of warrants	1,665,113
Settled RSU shares with cash	(254,110)	(179,922)
Net cash provided by (used in) financing activities	9,716,775	(179,922)
Net change in cash and restricted cash	403,534	7,421,701
Beginning cash and restricted cash balance	7,421,701
Ending cash and restricted cash balance	7,825,235	7,421,701
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid
Income taxes paid	1,637,102	182,925
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Initial Recognition of ROU Asset and Liability		73,749
Conversion of common shares into Series A Preferred		$ 3,000

Organization and Description of

Organization and Description of Business	12 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Organization and Description of Business	Note 1 – Organization and Description of Business Kaival Brands Innovations Group, Inc. (the “Company,” the “Registrant,” “we,” “us,” or “our”), formerly known as Quick Start Holdings, Inc., was incorporated on September 4, 2018 in the State of Delaware. Current Description of Business The Company is focused on growing and incubating innovative and profitable products into mature, dominant brands. On March 9, 2020, the Company entered into an exclusive distribution agreement (the “Distribution Agreement”) of certain electronic nicotine delivery systems (“ENDS”) and related components (the “Products”) with Bidi Vapor, LLC, a Florida limited liability company (“Bidi”), a related party company that is also owned by Nirajkumar Patel, the Chief Executive Officer of the Company. The Distribution Agreement was amended and restated on May 21, 2020, and again on April 20, 2021, (collectively the “A&R Distribution Agreement”), in order to clarify some of the provisions. Pursuant to the A&R Distribution Agreement, Bidi granted the Company an exclusive worldwide right to distribute the Products for sale and resale to non-retail level customers. Currently, the Products consist primarily of the “Bidi Stick.” The Company ceased all retail/direct-to-consumer sales in February 2021. In connection with the A&R Distribution Agreement, the Company entered into non-exclusive sub-distribution agreements, some of which were subsequently amended and restated by the parties in order to clarify certain provisions (all such agreements, as amended and restated, are collectively referred to as the “A&R Sub-Distribution Agreements”), whereby the Company appointed the counterparties as non-exclusive sub-distributors. Pursuant to the A&R Sub-Distribution Agreements, the sub-distributors agreed to purchase for resale the Products in such quantities as they should need to properly service non-retail customers within the continental United States (the “Territory”). On August 31, 2020 the Company formed Kaival Labs, Inc., a Delaware corporation (herein referred to as “Kaival Labs”) as a wholly owned subsidiary of the Company. On July 16, 2021, the Company filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a 1-for-12 reverse stock split (the “Reverse Stock Split”) of the shares of the Company’s common stock, par value $ 0.001 Current Product Offerings Pursuant to the A&R Distribution Agreement, The Company sells and resells electronic nicotine delivery systems, which it may refer to herein as “ENDS Products”, or “e-cigarettes”, to non-retail level customers. The sole Product the Company resells is the “BIDI ® ® On July 14, 2021, the Company announced plans to launch its first Kaival-branded product, a Hemp CBD product. In addition to its Kaival-branded formulation, the Company anticipates that it will also provide white label, wholesale solutions for other product manufacturers through its subsidiary, Kaival Labs. The Company has not yet launched any Kaival-branded product, nor has it begun to provide white label wholesale solutions for other product manufacturers. COVID-19 In January 2020, the World Health Organization (the “WHO”) announced a global health emergency because of a new strain of coronavirus (“COVID-19”) originating in Wuhan, China and the risks to the international community as the virus spread globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in global exposure. The Company’s operations have not been significantly impacted by COVID-19. No impairments were recorded as of October 31, 2021 and no triggering events or changes in circumstances had occurred. However, the full impact of the COVID-19 pandemic continues to evolve subsequent to the fiscal year ended October 31, 2021 and as of the date these consolidated financial statements are issued. As such, the full magnitude of the COVID-19 pandemic, and the resulting impact, if any, on the Company’s financial condition, liquidity, and future results of operations is uncertain. However, the Company was indirectly impacted by supply chain issues and regulatory oversight. First, COVID-19 impacted Bidi’s ability to quality test and develop its new product, the BIDI ® ® Impact of FDA PMTA Decision As of September 10, 2021, the FDA announced that it has taken action on over 93% of applications and issued Marketing Denial Orders (“MDOs”) for more than 1,167,000 flavored ENDS products, while issuing zero marketing authorizations. Bidi, along with nearly every other company in the ENDS industry, received a MDO for its non-tobacco flavored ENDS products. With respect to Bidi, the MDO covered all non-tobacco flavored BIDI® Sticks, including its Arctic (menthol) BIDI® Stick, which Bidi believes the FDA mischaracterized as “flavored.” BIDI believes that because its Arctic BIDI® Stick is menthol, it should not be subject to the MDO. Bidi and the Company believe this position is aligned with the FDA’s public statements and press releases stating that tobacco and menthol ENDS are not deemed flavored products subject to the MDOs. As a result, beginning in September 2021, Bidi pursued three avenues to challenge the MDO. First, on September 21, 2021, separate from the judicial appeal of the MDO in its entirety, Bidi filed a 21 C.F.R. § 10.75 internal FDA review request specifically of the decision to include the Arctic (menthol) BIDI® Stick in the MDO. The Company anticipates a decision from the FDA on the internal review in the second or third quarter of 2022, although we cannot provide any assurances as to the timing or outcome. Separately, on September 29, 2021, Bidi petitioned the U.S. Court of Appeals for the Eleventh Circuit to review the FDA’s denial of the PMTAs for its non-tobacco flavored BIDI® Stick ENDS, arguing that it was arbitrary and capricious under the Administrative Procedure Act (“APA”), as well as ultra vires Oral arguments in the merits-based proceeding are currently scheduled for May 2022. Finally, on October 14, 2021, Bidi requested FDA re-review the MDO and reconsider its position that Bidi did not include certain scientific data in its applications sufficient to allow the PMTAs to proceed to scientific review. In light of this request, on October 22, 2021 pursuant to 21 C.F.R. § 10.35(a), FDA issued an administrative stay of Bidi’s MDO pending its re-review . Subsequently, FDA lifted its administrative stay on December 17, 2021. Following the lifting of the FDA’s administrative stay, Bidi filed a renewed motion to stay the MDO with the U.S. Court of Appeals for the Eleventh Circuit, which was granted on February 1, 2022. In the event that the U.S. Court of Appeals issues for the Eleventh Circuit a ruling adverse to Bidi, or if FDA otherwise chooses to enforce against Bidi, Bidi will be forced to cease the continued sale of its non-tobacco flavored BIDI® Stick products in the United States, thereby resulting in the Company being unable to distribute such products, the Company’s business and financial condition would be materially adversely affected. The Company cannot provide any assurances as to the timing or outcome of the merits-based case. Risks and Uncertainties Historically, substantially all of the Company’s revenues were derived from sales of flavored BIDI® Sticks, including the Arctic (menthol) BIDI® Stick, sales of which constituted approximately 18.4% and 12.9% of its total sales of BIDI® Sticks for the fiscal years ended October 31, 2021 and 2020, respectively. The uncertainty of any potential decisions by the FDA leading up to the MDO negatively impacted the Company’s overall revenues for the last two quarters of fiscal 2021. Generally, substantially all of the ENDS industry’s revenue is derived from the sales of flavored products. In addition, Bidi has received approval to market and distribute products within 11 international markets, including the United Kingdom, France, Russia, and the Czech Republic. Bidi has also secured significant intellectual property protections similar to those received in the United States from the European Union, China, and several other regions and countries. It is also important to note that the nicotine formulation in the Bidi® Stick has been modified and approved at the 2% level to meet the criteria for distribution in the United Kingdom and Europe. These international market approvals Bidi has previously secured are for the full formulation lineup, including all flavors. Because the FDA’s PMTA restrictions and guidelines do not pertain to international markets, Bidi intends to continue manufacturing its full product lineup, for distribution by the Company in these international markets. The Company is also exploring potential partnerships with international distribution companies in order to possibly expand BIDI® Stick distribution more rapidly in these international markets.

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	12 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies	Note 2 – Basis of Presentation and Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the financial statements of the Company’s wholly-owned subsidiary, Kaival Labs. Intercompany transactions are eliminated. Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America (“GAAP”), and have been consistently applied in the preparation of the consolidated financial statements. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates. Cash and Restricted Cash The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at October 31, 2021and October 31,2020. Cash and restricted cash at October 31, 2021 and October 31, 2020 were $ 7,825,235 7,421,701 Cash and restricted consist of cash and cash held short-term in escrow as required. As of October 31, 2021, and October 31, 2020, the Company had $ 65,007 The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated balance sheet and the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows. Restrictions on Cash and Cash Equivalents October 31, October 31, 2021 2020 Cash $ 7,760,228 $ 7,421,701 Restricted cash 65,007 — Total cash and restricted cash shown in statement of cash flows $ 7,825,235 $ 7,421,701 Advertising and Promotion All advertising, promotion and marketing expenses, including commissions, are expensed when incurred. Accounts Receivable and Allowance for Doubtful Accounts Receivables are stated at cost, net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of accounts receivables. A considerable amount of judgment is required in assessing the amount of the allowance and the Company considers the historical level of credit losses and collection history and applies percentages to aged receivable categories. The Company makes judgments about the creditworthiness of debtors based on ongoing credit evaluations and monitors current economic trends that might impact the level of credit losses in the future. If the financial condition of the debtors were to deteriorate, resulting in their inability to make payments, a larger allowance may be required. As of October 31, 2021, based upon management’s assessment of the accounts receivable aging and the customers’ payment history, the Company has determined that no allowance for doubtful accounts is required. The Company had an allowance for doubtful accounts of $13,773, which was 1.0% of total accounts receivable customer balances, as of October 31, 2020. Inventories All product inventory is purchased from a related party, Bidi. Inventories are stated at the lower of cost and net realizable value. Cost includes all costs of purchase and other costs incurred in bringing the inventories to their present location and condition. The Company determines cost based on the FIFO method. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. All inventories are purchased from a related party of October 31, 2021, the inventories only consisted of finished goods, were significant and located in four storage locations, one of which is a related party, Bidi and one of which is a customer/sub distributor, Favs Business LLC (“Favs Business”). Based upon fiscal year 2021 inventory management procedures and their results, the Company has determined that no allowance for the inventory valuation is required at October 31, 2021. No inventory allowance was required as of October 31, 2020 either. Inventory deposit – related party The Company paid $2.9 million from its capital financing raise to Bidi, a related party, to have BIDI ® Revenue Recognition The Company adopted ASC 606, Revenue from Contracts with Customers Deferred Revenue The Company accepts partial payments for orders from wholesale customers, which it holds as deposits or deferred revenue, until the Company has received full payment and orders are shipped to the customer. Revenue for these orders is recognized at time of shipment to the customer. As of October 31, 2021 and October 31, 2020 the Company has received $ 0 623,096 Customer Refunds The Company infrequently has a need to adjust the size of an order after it has been shipped, received and paid for, due to the customer oversizing the order for more product that it can realistically sell at that time. If and when this occurs, the Company will ask the customer to return the over allotted product. Once received and inspected, the Company will issue a refund for the product return. As of October 31, 2021, the Company had one customer refund due for $316,800, which was the result of one of the Company’s sub distributor customers returning Product that had become defective in storage. The $316,800 amount at October 31, 2021 represents the amount of refund the Company will make to this customer. Products Revenue The Company generates products revenue from the sale of the Products (as defined above) to non-retail customers. The Company recognizes revenue at a point in time based on management’s evaluation of when performance obligations under the terms of a contract with the customer are satisfied and control of the Products has been transferred to the customer. In most situations, transfer of control is considered complete when the products have been shipped to the customer. The Company determined that a customer obtains control of the Product upon shipment when title of such product and risk of loss transfer to the customer. The Company’s shipping and handling costs are fulfillment costs and such amounts are classified as part of cost of sales. The Company’s sales arrangements for retail sales usually require full prepayment before delivery of the Products. The advance payment is not considered a significant financing component because the period between when the Company transfers a promised good to a customer and when the customer pays for that good is short. The Company offers credit sales arrangements to non-retail (or wholesale) customers and monitors the collectability of each credit sale routinely. Revenue is measured by the transaction price, which is defined as the amount of consideration expected to be received in exchange for providing goods to customers. The transaction price is adjusted for estimates of known or expected variable consideration, which includes refunds and returns as well as incentive offers and promotional discounts on current orders. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce revenue in the period of the sale. Variable consideration related to incentive offers and promotional programs are recorded as a reduction to revenue based on amounts the Company expects to collect. Estimates are regularly updated and the impact of any adjustments are recognized in the period the adjustments are identified. In many cases, key sales terms such as pricing and quantities ordered are established at the time an order is placed and incentives have very short-term durations. Amounts billed and due from customers are short term in nature and are classified as receivables since payments are unconditional and only the passage of time related to credit terms is required before payments are due. The Company does not grant payment financing terms greater than one year. Payments received in advance of revenue recognition are recorded as deferred revenue. Concentration of Revenues and Accounts Receivable For the fiscal year ended October 31, 2021, approximately 23%, or $13.9 million, of the revenue from the sale of Products, primarily consisting of the “BIDI ® Favs Business and C Store Master had outstanding balances of $1 million and, $0.3 million respectively, and accounted for approximately 50%, and 16%, respectively, of the total accounts receivable from customers as of October 31, 2021. For the year ended October 31, 2020, approximately 41% of the revenue from the sale of products, primarily consisting of the “BIDI® Stick,” was generated from Favs Business in the amount of approximately $26.4 million and approximately 6% of the revenue from the sale of products was generated from MMS Distro in the amount of approximately $3.9 million. Go Brands, Inc., with an outstanding balance of approximately $0.3 million and GPM Investment, LLC, with an outstanding balance of approximately $0.6 million, accounted for approximately 33% and 56% of the total accounts receivable from customers, respectively, as of October 31, 2020. Share-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments (share-based payments, or SBP) based on the grant-date fair value of the award. That cost is recognized over the period during which a recipient is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to conditions, compensation is not recognized until the performance condition is probable of occurrence. The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock-based awards on the date of grant and on each modification date. .Compensation expense for SBP awards granted to nonemployees is re-measured each period as the underlying options vest. The fair value of each option granted during the year ended October 31, 2021 and 2020 was estimated on the date of grant using the Black-Scholes option-pricing model with the weighted average assumptions in the following table: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions 2021 2020 Expected dividend yield 0 % — Expected option term (years) 10 — Expected volatility 294.55 301.53 % — Risk-free interest rate 1.19 1.63 % — The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Common Stock. The assumed discount rate was the default risk-free ten-year interest rate for US Treasury bills. The Company stock option expense for the year ended October 31, 2021 and October 31, 2020 was $ 1,773,947 0 The Company’s stock-based compensation for the fiscal years ended October 31, 2021 and October 31, 2020 was $ 9,449,421 769,437 Income Tax Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the recorded book basis and the tax basis of assets and liabilities for financial and income tax reporting. Deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income and tax credits that are available to offset future federal income taxes. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material adverse effect on the Company’s financial condition, results of operations, or cash flow. The Company has Federal net operating loss (“NOL”) carryforwards of approximately $ 4,000,000 1,800,000 A valuation allowance is recorded to reduce the deferred tax asset if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a valuation allowance of $ 1,256,059 . Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2021. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, restricted cash, accounts receivable, inventory, accounts payable and accrued expenses. Recent Accounting Pronouncements The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Going Concern

Going Concern	12 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 – Going Concern A recent court ruling on behalf of Bidi in the U.S. Court of Appeals for the Eleventh Circuit, granted a judicial stay of the MDO previously issued by the FDA to Bidi in September 2021. The ruling, issued on February 1, 2022, means that all BIDI® Stick flavors remain marketable by the Company in the United States, subject to the FDA’s enforcement discretion, while Bidi continues with its merits case challenging the legality of the MDO. As the FDA has indicated that it is prioritizing enforcement against companies that have not submitted PMTAs or who have MDOs in place, the Company views the risk of FDA enforcement against Bidi as low. Oral arguments in the merits case are currently scheduled in May 2022. If the U.S. Court of Appeals for the Eleventh Circuit agrees with Bidi in the merits case, the Company anticipates that FDA will be compelled to place the flavored ENDS back into the PMTA scientific review process. If this is the outcome of the merits case, the Company will be able to fully market and sell the Products, subject to the FDA’s enforcement discretion, until the scientific review process is complete on each of Bidi’s PMTA for flavored ENDS and the FDA issues its decision on each. If the U.S. Court of Appeals for the Eleventh Circuit disagrees with Bidi on the merits case, or if FDA otherwise chooses to enforce against Bidi, the Company will be forced to cease sales on the flavored ENDS in the United States market, leaving only the Tobacco and Menthol (Arctic) ENDS products for sale in the United States (pending the outcome of the specific PMTA filings and the administrative review request for the classification of “Arctic” as a standard menthol ENDS). If this is the outcome of the merits case, this combined with the negative cash flows from operations raises substantial doubt on the Company’s ability to continue as a going concern. Management plans to continue similar operations with increased marketing, which the Company believes will result in increased revenue and net income. However, there is no assurance that management’s plan will be successful due to the current economic climate in the United States and globally. These audited consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that we cannot continue as a going concern.

Leases

Leases	12 Months Ended
	Oct. 31, 2021
Leases
Leases	Note 4 – Leases The Company capitalizes all leased assets pursuant to ASU 2016-02, “Leases (Topic 842),” which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. The Company adopted the standard in the fourth quarter of fiscal year 2020. The adoption of the amended ASU 2016-02 did not have any impact on the Company’s previously reported financial statements in any prior period nor did it result in a cumulative effect adjustment to retained earnings T he Company does not have financing leases and only one operating lease for office space, with a related party. The operating lease is for a term of 5 1,000 4.5 55,604 73,749 14,529 3,616 2,836 13,020 46,185 59,205 Schedule of Future Minimum Rental Payments for Operating Leases 2021 2022 2023 2024 Total Lease payments $ 13,500 $ 15,300 $ 18,000 $ 13,500 $ 60,300 Less discount imputed interest (1,095 ) Present value of future payments 59,205 Less current obligations (13,020 ) Long term lease obligations $ 46,185 On November 1, 2021 the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made one payment on this lease in the amount of $ 2,143 10,713

Stockholder Equity

Stockholder Equity	12 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Stockholder Equity	Note 5 – Stockholder Equity Additional Paid-In Capital The Company’s Chief Executive Officer, Mr. Nirajkumar Patel, paid expenses on behalf of the Company totaling $ 16,257 The Company’s Chief Operating Officer, Mr. Eric Mosser, paid expenses on behalf of the Company totaling $ 10,900 Preferred Shares Issued On August 19, 2020, the Company issued 3,000,000 300,000,000 The authorized preferred stock of the Company consists of 5,000,000 0.001 3,000,000 3,000,000 Common Shares Issued On November 1, 2020, the Company entered into a Consulting Agreement with Inflection Partners LLC (“Inflection Partners”), pursuant to which the Company engaged Inflection Partners to provide investor relations, corporate communication, marketing, strategic advising, and operational activities (collectively, the “Inflection Services”), in exchange for a $ 45,000 60,000 83,333 83,333 125,000 45,000 60,000 83,333 166,667 308,333 The Company implemented the Reverse Stock Split, effective prior to the opening of the market on Tuesday, July 20, 2021. The Reverse Stock Split was implemented by the Company in support of its application to list on the Nasdaq Capital Market (“Nasdaq”). As a result of the Reverse Stock Split at the 1-for-12 ratio, every 12 shares of the Common Stock was exchanged for one share of the Common Stock. The authorized Common Stock of the Company consists of 1,000,000,000 0.001 30,195,312 23,106,886 In September 2021, the Company completed a firm commitment underwritten offering, which offering was made pursuant to its Registration Statement on Form S-3 (File No. 333-258339) (the “Registration Statement”). The Securities and Exchange Commission (the “SEC”) declared the Registration Statement effective on August 10, 2021. The Company sold 4,700,000 million shares of our Common Stock and warrants, with an exercise price of $1.90 per share and an expiration of five years, to purchase an additional 3,525,000 705,000 528,750 8,305,772 879,828 During the year ended October 31, 2020, 318,671 611,177 During the year ended October 31, 2021, 674,803 8,944,100 Warrants Shares Issued The weighted average remaining of the outstanding Common Stock warrants is 4.92 As part of the underwritten offering, the Company issued warrants to purchase a total of 4,053,750 1.90 879,828 1,665,113 0 The following is a summary of the stock warrant plan activity during the years ended October 31, 2021 and 2020. Share-based Payment Arrangement, Option, Activity 2021 2020 Number of Warrants Weighted Average Exercise Price Number of Warrants Weighted Average Exercise Price Warrants Outstanding at Beginning of the year — $ — — $ — Granted 4,053,750 1.90 — — Exercised (879,828) 1.90 — — Canceled, forfeited, expired — 1.90 — — Warrants Outstanding and Exercisable at End of Year 3,173,922 $ 1.90 — $ — Restricted Stock Unit Awards During the fiscal year October 31, 2021: During the twelve months ended October 31, 2021, 221,666 505,321 92,871 254,110 23,333 RSUs Accordingly, there remains 499,167 1,011,019 On January 1, 2021, the Board of Directors approved the award of 41,667 315,000 During the fiscal year October 31, 2020: On May 28, 2020, the Board of Directors approved the award of 729,167 RSUs under the Incentive Plan to six employees. The RSUs were awarded pursuant to RSU Agreements, which provide for vesting over the course of three years, with a portion of the RSUs vesting every three months. The vesting schedules are set forth in the applicable RSU Agreements. On June 1, 2020, the Board of Directors approved the award of 83,333 RSUs under the Incentive Plan to one newly-hired employee. The RSUs were awarded pursuant to a RSU Agreement, which provide for vesting over the course of three years, with a portion of the RSUs vesting every three months. The vesting schedules are set forth in the applicable RSU Agreement. On July 26, 2020, the Company amended the RSU award agreements previously entered into with employees to include the option for employees of receiving a combination of cash and shares for their bonus, at the discretion of the Company. Any cash portion paid will be equal to the fair market value of the vested RSUs. The Company evaluated the amendments under ASC 718 and determined the amendment did not qualify as a modification. Any difference in the amount paid in cash and the fair market value of the shares purchased is recorded as additional compensation. These shares were valued at fair market value on the grant dates, using the closing share price for those dates, for a total of $ 1,359,600 110,000 158,260 Of the shares issued to employees, 18,833 shares were withheld by the Company to satisfy tax withholding obligations equal to $ 223,763 The shares had a fair market value on the settlement date of $179,922. The difference in the amount paid and fair market value was $49,743 and was recorded as additional compensation Stock Option Awards During fiscal year 2021, the Company granted options exercisable for up to 150,000 shares of Common Stock of which 41,667 fully vested on December 1, 2021, 15,000 fully vested on March 17, 2021, 7,500 fully vested on June 30, 2021, 68,333 vest over the next 2 years on March 17, 2022, and 2023, and 17,500 vest over the next 2 years on June 30, 2022 and 2023. The options have exercise prices ranging from $9.12 to $28.68 per share. These options have a weighted average remaining life of 9.43 years as of October 31, 2021 and expire in the year 2031. The Company fair valued the options on the grant date at $ 3,088,002 $9.12 27.36 294.55 301.53 10 1.19 1.63 1,773,947 1,314,055

Related-Party Transactions

Related-Party Transactions	12 Months Ended
	Oct. 31, 2021
Related Party Transactions [Abstract]
Related-Party Transactions	Note 6 – Related-Party Transactions Revenue and Accounts Receivable During the fiscal year ended October 31, 2021, the Company recognized revenue of $ 154,560 During the fiscal year ended October 31, 2020, the Company recognized revenue of $ 233,955 15,360 Purchases and Accounts Payable During the fiscal year ended October 31, 2021, the Company purchased Products equal to $91,149,783 from Bidi, a related party company that is also owned by Nirajkumar Patel, the Company’s Chief Executive Officer, and after returns of $29,283,452 , resulted in the net amount of $61,866,332 in product purchases. As of October 31, 2021, the Company had accounts payable to Bidi of $12,667,769. During the fiscal year ended October 31, 2021, Lakshmi Distributors Inc., doing business as C Store Master (“C Store Master”), a large customer of the Company, elected to return the inventory associated with the consignment order placed on April 1, 2021, which was located at the staging warehouse in California, to the Company at no cost. The Company then returned this same inventory to Bidi’s warehouse in Florida at no cost. This reduced the Company’s inventory and reduced the related-party amount due to Bidi by $ 13,846,950 During the year ended October 31, 2020, the Company purchased Products with a value of $ 53,981,351 1,409,561 Office Space and Other Leases On August 1, 2020, the Company began leasing office space for its main corporate office in Grant, Florida. The five-year lease agreement is with a related party, Just Pick, LLC (“Just Pick”). The Company’s Chief Executive Officer is an officer of Just Pick. During fiscal year 2021 the Company was not being charged for the leased space under the terms and conditions of the lease between the Company and Just Pic k , was not being charged for the separate warehouse space provided by Just Pick, Concentration of Purchases and Accounts Payable- Related Party For the years ended October 31, 2021 and 2020, 100% of the inventories of Products, primarily consisting of the “BIDI® Stick,” were purchased from Bidi, a related party company that is owned by Nirajkumar Patel, our Chief Executive Officer, in the amount of approximately$ 61.9 54.0 Concentration of Revenues and Accounts Receivable For the fiscal year ended October 31, 2021, approximately 23%, or $ 13.9 ® 9.6 8.2 Favs Business and C Store Master had outstanding balances of $ 1 0.3 50 16 For the year ended October 31, 2020, approximately 41% of the revenue from the sale of products, primarily consisting of the “BIDI® Stick,” was generated from Favs Business in the amount of approximately $26.4 million and approximately 6% of the revenue from the sale of products was generated from MMS Distro in the amount of approximately $3.9 million. Go Brands, Inc., with an outstanding balance of approximately $0.3 million and GPM Investment, LLC, with an outstanding balance of approximately $0.6 million, accounted for approximately 33% and 56% of the total accounts receivable from customers, respectively, as of October 31, 2020.

Income Tax

Income Tax	12 Months Ended
	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Income Tax	Note 8 – Income Tax The Company is subject to federal income taxes and state income tax in the U.S. Significant judgment is required in determining the provision for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws. The Tax Cuts and Jobs Act (the “Tax Act”) was enacted on December 22, 2017 and reduced the U.S. federal corporate tax rate from 35 21 4.458 Significant components of the tax expense (benefit) recognized in the accompanying statements of operations for the years ended October 31, 2021 and October 31, 2020 are as follows: Schedule of Components of Income Tax Expense (Benefit) October 31, 2021 2020 Current Tax Expense: Federal $ (1,301,008 ) $ 1,249,525 State (134,190 ) 265,256 Total Current Tax Expense (1,435,198 ) 1,514,781 Deferred Tax Expense: Federal — — State — — Total Deferred Tax Expense — — Estimated Tax Payments: Federal — — State — 182,925 Total Estimated Tax Payment — 182,925 Net Income Tax Liability/(Benefit) $ (1,435,198 ) $ 1,331,856 Total net deferred taxes are comprised of the following at October 31, 2021 and October 31, 2020: Schedule of Deferred Tax Assets and Liabilities October 31, 2021 2020 Deferred Tax Assets: Stock Compensation Expense – NQSO $ 384,540 $ — Other 30,099 — Net Operating Loss Carryforwards 910,685 — Total Deferred Tax Asset 1,325,324 — Deferred Tax Liabilities: Prepaid Expenses (69,265 ) — Total Deferred Tax Liabilities (69,265 ) — Less: Valuation Allowance (1,256,059 ) — Net Deferred Tax Asset — — The Company has Federal NOL carryforwards of approximately $ 4,000,000 1,800,000 A valuation allowance is recorded to reduce the deferred tax asset if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a valuation allowance of $ 1,256,059 During the year ended October 31, 2021, the Company paid $1,637,102 in combined Federal/State income taxes for taxable income generated in fiscal year 2020. As of October 31, 2021, the Company had a total income tax receivable in the amount of $ 1,753,594 During the year ended October 31, 2020, the Company generated taxable income of $5,950,117 and, thus, accrued $1,249,525 of federal income tax. Estimated state income tax of $182,925 was paid to the state of Florida based on taxable income for the nine months ended July 31, 2020. The accrued expense for state taxes was $ 82,331 182,925 1,331,856

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9 – Commitments and Contingencies The Company follows ASC 450-20, Los Contingencies, Patent Contribution Agreement On May 4, 2021, Next Generation Labs, LLC (“Next Generation”) notified the Company that a “reversion event” had occurred under that certain Patent Contribution Agreement, dated September 28, 2020 (the “Patent Contribution Agreement”). Pursuant to the Patent Contribution Agreement, Next Generation agreed to contribute certain patents, patent applications, and patent data, described on Exhibit “A” of the Patent Contribution Agreement (the “Patents”), to the Company and the Company would subsequently transfer the Patents to Kaival Labs. Pursuant to the Patent Contribution Agreement, the Company agreed to pay Next Generation a purchase price of $3 million for the Patents (the “Purchase Price”), which was expected to be paid over-time upon two events. First, the Company expected to pay part of the Purchase Price from proceeds generated from a future securities offering (the “Offering Payment”). Additionally, on the first date that Kaival Labs sold a product that was developed using any portion of the Patents or based on the Patents, the Company agreed to pay Next Generation the difference between the Purchase Price and the Offering Payment. Pursuant to the terms of the Patent Contribution Agreement, the parties agreed that the Company would file a Form 1-A offering statement no later than January 31, 2021, unless extended in writing by the Company in good faith to no later than March 15, 2021 (the “Filing Date”). The Patent Contribution Agreement further provided that in the event the Company or Kaival Labs materially breached the terms of the Patent Contribution Agreement and the material breach is not cured within fifteen (15) business days after Next Generation provides written notice of such material breach, then a reversion event would occur, and the Patents would revert from Kaival Labs to Next Generation. The Company did not undertake a securities offering by filing a Form 1-A offering statement by the Filing Date. The Company attempted to negotiate an amendment to the Patent Contribution Agreement, which would allow the Company additional time to undertake a securities offering. However, on April 8, 2021, Next Generation notified the Company that it was in material breach of the Patent Contribution Agreement and that the Company would have fifteen (15) business days, or April 30, 2021, to cure such breach. Ultimately, the Company decided not to cure such breach within the requisite time and, on May 4, 2021, Next Generation notified the Company that a reversion event occurred. The Company has completed the process of completing the necessary documentation to transfer the Patents from Kaival Labs to Next Generation. Neither the Company, nor Kaival Labs, had developed or otherwise relied on the Patents to date and does not expect the reversion of the Patents to materially affect the Company’s business. Consulting Agreement On March 17, 2021, the Company entered into a consulting agreement with Russell Quick, which granted stock options to purchase 41,667 28.68 1,139,998 Executive Compensation On May 28, 2020, the Board of Directors approved cash bonus awards to each of the Chief Executive Officer and the Chief Operating Officer. With respect to the Chief Executive Officer, the Board of Directors approved a cash bonus award equal to $30,000 for every $25 million in gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board of Directors approved a cash bonus award equal to $20,000 for every $25 million in gross revenues generated by the Company. On May 28, 2020, the Board of Directors also approved an equity bonus award for each of the Chief Executive Officer and the Chief Operating Officer. With respect to the Chief Executive Officer, the Board of Directors approved an award of 90,000 restricted shares of the Company’s Common Stock for every $50 million in accumulated gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board of Directors approved an award of 75,000 restricted shares of the Company’s Common Stock for every $50 million in accumulated gross revenues generated by the Company 165,000 QuikfillRx Service Agreement On June 2, 2020, the Company entered into the First Amendment to the Service Agreement with QuikfillRx (collectively with the “Amended Service Agreement”) with QuikfillRx, whereby QuikfillRx provides the Company with certain services and support relating to sales management, website development and design, graphics, content, public communication, social media, management and analytics, and market and other research (collectively, the “Services”). The Services are provided by QuikfillRx as requested from time to time by the Company. . Pursuant to the terms of the amendment, the parties modified the amount of General Compensation (as defined below) to be paid to QuikfillRx. “General Compensation’’ consists of the following: (i) for the Services provided in March 2020, the Company paid QuikfillRx an amount equal to $86,000; (ii) for the Services provided in April 2020, the Company paid QuikfillRx an amount equal to $100,000; (iii) each calendar month commencing May 2020 through October 2020, the Company paid QuikfillRx an amount equal to $125,000 per month for the Services to be performed during such calendar month; (iv) if the parties agree to extend the term of the Amended Service Agreement beyond the original expiration date of October 31, 2020, then for the period between November 1, 2020 and October 31, 2021, the Company will pay QuikfillRx $125,000 per month for the Services to be performed during such calendar month; and (iv) if the parties agree to extend the term of the Amended Service Agreement beyond October 31, 2021, then for the period between November 1, 2021 and October 31, 2022, the Company will pay QuikfillRx $150,000 per month for the Services to be performed during such calendar month ● An amount equal to 0.9% of the Applicable Gross Quarterly Sales (as defined in the Amended Service Agreement), which amount shall, at the Company’s option be paid in (a) cash or (b) shares of the Company’s common stock, or (c) a combination of cash and common stock. ● An amount equal to 0.27% of the Applicable Gross Quarterly Sales, which amount must be paid in cash. The Company accrued $ 79,592 3,775

Subsequent Events

Subsequent Events	12 Months Ended
	Oct. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 10 – Subsequent Events On February 4, 2022, the Company entered into a Consulting Agreement with Oakhill Europe Ltd (“Oakhill Europe”), pursuant to which the Company engaged Oakhill Europe to provide strategic advising and negotiation assistance for potential international distribution agreements (collectively, the “Oakhill Services”), in exchange for a $15,000 monthly retainer, incentive compensation bonuses of up to $175,000, and an incentive compensation bonus value of $75,000 paid in fully-vested non-qualified stock options, upon the achievement of certain events Share-based Compensation On November 11, 2021, the Company issued 61,250 23,243 124,612

Basis of Presentation and Sig_2

Basis of Presentation and Significant Accounting Policies (Policies)	12 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the financial statements of the Company’s wholly-owned subsidiary, Kaival Labs. Intercompany transactions are eliminated.
Basis of Presentation	Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America (“GAAP”), and have been consistently applied in the preparation of the consolidated financial statements.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.
Cash and Restricted Cash	Cash and Restricted Cash The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at October 31, 2021and October 31,2020. Cash and restricted cash at October 31, 2021 and October 31, 2020 were $ 7,825,235 7,421,701 Cash and restricted consist of cash and cash held short-term in escrow as required. As of October 31, 2021, and October 31, 2020, the Company had $ 65,007 The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated balance sheet and the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows. Restrictions on Cash and Cash Equivalents October 31, October 31, 2021 2020 Cash $ 7,760,228 $ 7,421,701 Restricted cash 65,007 — Total cash and restricted cash shown in statement of cash flows $ 7,825,235 $ 7,421,701
Advertising and Promotion	Advertising and Promotion All advertising, promotion and marketing expenses, including commissions, are expensed when incurred.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Receivables are stated at cost, net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of accounts receivables. A considerable amount of judgment is required in assessing the amount of the allowance and the Company considers the historical level of credit losses and collection history and applies percentages to aged receivable categories. The Company makes judgments about the creditworthiness of debtors based on ongoing credit evaluations and monitors current economic trends that might impact the level of credit losses in the future. If the financial condition of the debtors were to deteriorate, resulting in their inability to make payments, a larger allowance may be required. As of October 31, 2021, based upon management’s assessment of the accounts receivable aging and the customers’ payment history, the Company has determined that no allowance for doubtful accounts is required. The Company had an allowance for doubtful accounts of $13,773, which was 1.0% of total accounts receivable customer balances, as of October 31, 2020.
Inventories	Inventories All product inventory is purchased from a related party, Bidi. Inventories are stated at the lower of cost and net realizable value. Cost includes all costs of purchase and other costs incurred in bringing the inventories to their present location and condition. The Company determines cost based on the FIFO method. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. All inventories are purchased from a related party of October 31, 2021, the inventories only consisted of finished goods, were significant and located in four storage locations, one of which is a related party, Bidi and one of which is a customer/sub distributor, Favs Business LLC (“Favs Business”). Based upon fiscal year 2021 inventory management procedures and their results, the Company has determined that no allowance for the inventory valuation is required at October 31, 2021. No inventory allowance was required as of October 31, 2020 either.
Inventory deposit – related party	Inventory deposit – related party The Company paid $2.9 million from its capital financing raise to Bidi, a related party, to have BIDI ®
Revenue Recognition	Revenue Recognition The Company adopted ASC 606, Revenue from Contracts with Customers
Deferred Revenue	Deferred Revenue The Company accepts partial payments for orders from wholesale customers, which it holds as deposits or deferred revenue, until the Company has received full payment and orders are shipped to the customer. Revenue for these orders is recognized at time of shipment to the customer. As of October 31, 2021 and October 31, 2020 the Company has received $ 0 623,096
Customer Refunds	Customer Refunds The Company infrequently has a need to adjust the size of an order after it has been shipped, received and paid for, due to the customer oversizing the order for more product that it can realistically sell at that time. If and when this occurs, the Company will ask the customer to return the over allotted product. Once received and inspected, the Company will issue a refund for the product return. As of October 31, 2021, the Company had one customer refund due for $316,800, which was the result of one of the Company’s sub distributor customers returning Product that had become defective in storage. The $316,800 amount at October 31, 2021 represents the amount of refund the Company will make to this customer.
Products Revenue	Products Revenue The Company generates products revenue from the sale of the Products (as defined above) to non-retail customers. The Company recognizes revenue at a point in time based on management’s evaluation of when performance obligations under the terms of a contract with the customer are satisfied and control of the Products has been transferred to the customer. In most situations, transfer of control is considered complete when the products have been shipped to the customer. The Company determined that a customer obtains control of the Product upon shipment when title of such product and risk of loss transfer to the customer. The Company’s shipping and handling costs are fulfillment costs and such amounts are classified as part of cost of sales. The Company’s sales arrangements for retail sales usually require full prepayment before delivery of the Products. The advance payment is not considered a significant financing component because the period between when the Company transfers a promised good to a customer and when the customer pays for that good is short. The Company offers credit sales arrangements to non-retail (or wholesale) customers and monitors the collectability of each credit sale routinely. Revenue is measured by the transaction price, which is defined as the amount of consideration expected to be received in exchange for providing goods to customers. The transaction price is adjusted for estimates of known or expected variable consideration, which includes refunds and returns as well as incentive offers and promotional discounts on current orders. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce revenue in the period of the sale. Variable consideration related to incentive offers and promotional programs are recorded as a reduction to revenue based on amounts the Company expects to collect. Estimates are regularly updated and the impact of any adjustments are recognized in the period the adjustments are identified. In many cases, key sales terms such as pricing and quantities ordered are established at the time an order is placed and incentives have very short-term durations. Amounts billed and due from customers are short term in nature and are classified as receivables since payments are unconditional and only the passage of time related to credit terms is required before payments are due. The Company does not grant payment financing terms greater than one year. Payments received in advance of revenue recognition are recorded as deferred revenue. Concentration of Revenues and Accounts Receivable For the fiscal year ended October 31, 2021, approximately 23%, or $13.9 million, of the revenue from the sale of Products, primarily consisting of the “BIDI ® Favs Business and C Store Master had outstanding balances of $1 million and, $0.3 million respectively, and accounted for approximately 50%, and 16%, respectively, of the total accounts receivable from customers as of October 31, 2021. For the year ended October 31, 2020, approximately 41% of the revenue from the sale of products, primarily consisting of the “BIDI® Stick,” was generated from Favs Business in the amount of approximately $26.4 million and approximately 6% of the revenue from the sale of products was generated from MMS Distro in the amount of approximately $3.9 million. Go Brands, Inc., with an outstanding balance of approximately $0.3 million and GPM Investment, LLC, with an outstanding balance of approximately $0.6 million, accounted for approximately 33% and 56% of the total accounts receivable from customers, respectively, as of October 31, 2020.
Share-Based Compensation	Share-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments (share-based payments, or SBP) based on the grant-date fair value of the award. That cost is recognized over the period during which a recipient is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to conditions, compensation is not recognized until the performance condition is probable of occurrence. The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock-based awards on the date of grant and on each modification date. .Compensation expense for SBP awards granted to nonemployees is re-measured each period as the underlying options vest. The fair value of each option granted during the year ended October 31, 2021 and 2020 was estimated on the date of grant using the Black-Scholes option-pricing model with the weighted average assumptions in the following table: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions 2021 2020 Expected dividend yield 0 % — Expected option term (years) 10 — Expected volatility 294.55 301.53 % — Risk-free interest rate 1.19 1.63 % — The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Common Stock. The assumed discount rate was the default risk-free ten-year interest rate for US Treasury bills. The Company stock option expense for the year ended October 31, 2021 and October 31, 2020 was $ 1,773,947 0 The Company’s stock-based compensation for the fiscal years ended October 31, 2021 and October 31, 2020 was $ 9,449,421 769,437
Income Tax	Income Tax Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the recorded book basis and the tax basis of assets and liabilities for financial and income tax reporting. Deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income and tax credits that are available to offset future federal income taxes. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material adverse effect on the Company’s financial condition, results of operations, or cash flow. The Company has Federal net operating loss (“NOL”) carryforwards of approximately $ 4,000,000 1,800,000 A valuation allowance is recorded to reduce the deferred tax asset if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a valuation allowance of $ 1,256,059 .
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2021. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, restricted cash, accounts receivable, inventory, accounts payable and accrued expenses.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Basis of Presentation and Sig_3

Basis of Presentation and Significant Accounting Policies (Tables)	12 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Restrictions on Cash and Cash Equivalents	Restrictions on Cash and Cash Equivalents October 31, October 31, 2021 2020 Cash $ 7,760,228 $ 7,421,701 Restricted cash 65,007 — Total cash and restricted cash shown in statement of cash flows $ 7,825,235 $ 7,421,701
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions 2021 2020 Expected dividend yield 0 % — Expected option term (years) 10 — Expected volatility 294.55 301.53 % — Risk-free interest rate 1.19 1.63 % —

Leases (Tables)

Leases (Tables)	12 Months Ended
	Oct. 31, 2021
Leases
Schedule of Future Minimum Rental Payments for Operating Leases	Schedule of Future Minimum Rental Payments for Operating Leases 2021 2022 2023 2024 Total Lease payments $ 13,500 $ 15,300 $ 18,000 $ 13,500 $ 60,300 Less discount imputed interest (1,095 ) Present value of future payments 59,205 Less current obligations (13,020 ) Long term lease obligations $ 46,185

Stockholder Equity (Tables)

Stockholder Equity (Tables)	12 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Share-based Payment Arrangement, Option, Activity	Share-based Payment Arrangement, Option, Activity 2021 2020 Number of Warrants Weighted Average Exercise Price Number of Warrants Weighted Average Exercise Price Warrants Outstanding at Beginning of the year — $ — — $ — Granted 4,053,750 1.90 — — Exercised (879,828) 1.90 — — Canceled, forfeited, expired — 1.90 — — Warrants Outstanding and Exercisable at End of Year 3,173,922 $ 1.90 — $ —

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	Schedule of Components of Income Tax Expense (Benefit) October 31, 2021 2020 Current Tax Expense: Federal $ (1,301,008 ) $ 1,249,525 State (134,190 ) 265,256 Total Current Tax Expense (1,435,198 ) 1,514,781 Deferred Tax Expense: Federal — — State — — Total Deferred Tax Expense — — Estimated Tax Payments: Federal — — State — 182,925 Total Estimated Tax Payment — 182,925 Net Income Tax Liability/(Benefit) $ (1,435,198 ) $ 1,331,856
Schedule of Deferred Tax Assets and Liabilities	Schedule of Deferred Tax Assets and Liabilities October 31, 2021 2020 Deferred Tax Assets: Stock Compensation Expense – NQSO $ 384,540 $ — Other 30,099 — Net Operating Loss Carryforwards 910,685 — Total Deferred Tax Asset 1,325,324 — Deferred Tax Liabilities: Prepaid Expenses (69,265 ) — Total Deferred Tax Liabilities (69,265 ) — Less: Valuation Allowance (1,256,059 ) — Net Deferred Tax Asset — —

Organization and Description _2

Organization and Description of Business (Details Narrative) - $ / shares	Oct. 31, 2021	Oct. 31, 2020
Accounting Policies [Abstract]
Common stock, par value	$ 0.001	$ 0.001

Basis of Presentation and Sig_4

Basis of Presentation and Significant Accounting Policies (Details - Restricted on Cash) - USD ($)	Oct. 31, 2021	Oct. 31, 2020
Accounting Policies [Abstract]
Cash	$ 7,760,228	$ 7,421,701
Restricted cash	65,007
Total cash and restricted cash shown in statement of cash flows	$ 7,825,235	$ 7,421,701

Basis of Presentation and Sig_5

Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Property, Plant and Equipment [Line Items]
Expected dividend yield	0.00%
Expected option term (years)	10 years
Expected volatility
Risk-free interest rate	1.19%
Risk-free interest rate	1.63%
Risk-free interest rate
Minimum [Member]
Property, Plant and Equipment [Line Items]
Expected volatility	294.55%
Risk-free interest rate	1.19%
Maximum [Member]
Property, Plant and Equipment [Line Items]
Expected volatility	301.53%
Risk-free interest rate	1.63%

Basis of Presentation and Sig_6

Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2019
Accounting Policies [Abstract]
Cash and cash equivalents	$ 7,825,235	$ 7,421,701
Restricted cash	65,007
Deposits from customers	0	623,096
Stock option expense	1,773,947	0
Stock-based compensation	9,449,421	769,437
Net operating loss	4,000,000	$ 1,800,000
Valuation allowance	$ 1,256,059

Leases (Details)

Leases (Details) - USD ($)	Oct. 31, 2021	Oct. 31, 2020
Leases
2021	$ 13,500
2022	15,300
2023	18,000
2024	13,500
Total	60,300
Less discount	(1,095)
Present value of future payments	59,205
Less current obligations	(13,020)	$ (11,709)
Long term lease obligations	$ 46,185	$ 59,204

Leases (Details Narrative)

Leases (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2021	Dec. 15, 2021	Oct. 31, 2020
Leases
Lease term	5 years
Rent per month	$ 1,000
Current borrowing rate	4.50%
Right to use lease asset	$ 55,604		$ 70,133
Recognition of ROU operating lease	73,749
Recognition of ROU liability	14,529
Amortization expense for right to use asset	3,616
Payment of ROU liability	2,836
Short-term ROU lease liability	13,020		11,709
Long term lease liability	46,185		$ 59,204
Lease liability	59,205
Operating lease expense	$ 2,143
Lease amount		$ 10,713

Stockholder Equity (Details)

Stockholder Equity (Details) - $ / shares	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding at Ending	879,828
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding at Beginning
Weighted Average Exercise Price at Beginning
Number of warrants, Granted	4,053,750
Weighted Average Exercise Price, Granted	$ 1.90
Number of warrants, Exercised	(879,828)
Weighted Average Exercise Price, Exercised	$ 1.90
Number of warrants, Cancelled, forfeited, expired
Weighted Average Exercise Price, Cancelled, forfeited, expired	$ 1.90
Warrants Outstanding at Ending	3,173,922
Weighted Average Exercise Price at Ending	$ 1.90

Stockholder Equity (Details Nar

Stockholder Equity (Details Narrative) - USD ($)	Jul. 20, 2021	Jan. 06, 2021	Jan. 02, 2021	Sep. 30, 2021	Oct. 31, 2021	Oct. 31, 2020	Nov. 02, 2020	Aug. 19, 2020
Class of Stock [Line Items]
Proceeds from Contributions from Affiliates						$ 27,157
Common stock, shares authorized					1,000,000,000	1,000,000,000
Preferred stock, shares authorized					5,000,000	5,000,000
Reverse stock split, description	Reverse Stock Split at the 1-for-12 ratio, every 12 shares of the Common Stock was exchanged for one share of the Common Stock.
Common stock, par value					$ 0.001	$ 0.001
Common stock, shares issued					30,195,312	23,106,886
Common stock, shares outstanding					30,195,312	23,106,886
Purchase of additional shares				3,525,000
Net offering cost					$ 8,305,772
Exercise of warrants					879,828
Additional Collateral, Aggregate Fair Value					$ 8,944,100
Issuance of warrants					4,053,750
Exercise price					$ 1.90
Warrants exercised					$ 1,665,113
Aggregate intrinsic value					0
Share-based compensation					9,449,421	$ 769,437
Obligations value					$ 254,110
Stock option awards, description					Company granted options exercisable for up to 150,000 shares of Common Stock of which 41,667 fully vested on December 1, 2021, 15,000 fully vested on March 17, 2021, 7,500 fully vested on June 30, 2021, 68,333 vest over the next 2 years on March 17, 2022, and 2023, and 17,500 vest over the next 2 years on June 30, 2022 and 2023. The options have exercise prices ranging from $9.12 to $28.68 per share. These options have a weighted average remaining life of 9.43 years as of October 31, 2021 and expire in the year 2031.
Fair valued of options granted					$ 3,088,002
Volatility range
Expected term					10 years
Risk-free interest rate
Stock option expense					$ 1,773,947
Unamortized stock option expense					$ 1,314,055
Minimum [Member]
Class of Stock [Line Items]
Stock price					$ 9.12
Volatility range					294.55%
Risk-free interest rate					1.19%
Maximum [Member]
Class of Stock [Line Items]
Stock price					$ 27.36
Volatility range					301.53%
Risk-free interest rate					1.63%
Employee Stock [Member]
Class of Stock [Line Items]
Purchase of additional shares					92,871
Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Purchase of additional shares			41,667		221,666
Share-based compensation					$ 505,321
Forfeited of shares					23,333
Remainning unvestes shares					499,167
Unamortized stock expenses					$ 1,011,019
Fair value of grant			$ 315,000
Consulting Agreement [Member]
Class of Stock [Line Items]
Deposits		$ 45,000					$ 45,000
Retainage Deposit		$ 60,000					$ 60,000
Consulting Agreement [Member] | Restricted Stock [Member]
Class of Stock [Line Items]
Shares, Issued		83,333					83,333
[custom:IncentiveCompensationOfShares-0]		166,667					83,333
[custom:PurchaseOfWarrants-0]							125,000
Shares issued for services		308,333
Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares authorized								300,000,000
Shares issued for services					674,803
Purchase of additional shares				705,000
Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized					5,000,000
Preferred stock, par value					$ 0.001
Warrant [Member]
Class of Stock [Line Items]
Purchase of additional shares				528,750
Issuance of warrants					879,828
Common Stock Warrants [Member]
Class of Stock [Line Items]
Weighted average remaining term					4 years 11 months 1 day
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares issued					3,000,000	3,000,000
Preferred stock, shares authorized					3,000,000	3,000,000		3,000,000
Preferred stock, par value					$ 0.001	$ 0.001
Chief Financial Officer [Member]
Class of Stock [Line Items]
Proceeds from Contributions from Affiliates					$ 16,257
Chief Operating Officer [Member]
Class of Stock [Line Items]
Proceeds from Contributions from Affiliates					10,900
KH [Member] | Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares issued								3,000,000
TwoNonEmployees [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Issued for Services					$ 318,671
Stock Issued During Period, Shares, Issued for Services					611,177
Seven Employees [Member] | Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Fair value of shares vested					$ 1,359,600
Shares granted for compensation, shares					110,000
Shares granted for compensation, value					$ 158,260
Stock issued for cash					$ 223,763
Compensation description					The shares had a fair market value on the settlement date of $179,922. The difference in the amount paid and fair market value was $49,743 and was recorded as additional compensation

Related-Party Transactions (Det

Related-Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Related Party Transaction [Line Items]
Revenues	$ 58,776,430	$ 64,314,379
Revenue from related parties	154,560	233,955
Accounts receivable from related parties		15,360
[custom:PurchasesAndAccountsPayableDescription]	Company purchased Products equal to $91,149,783 from Bidi, a related party company that is also owned by Nirajkumar Patel, the Company’s Chief Executive Officer, and after returns of $29,283,452 , resulted in the net amount of $61,866,332  in product purchases. As of October 31, 2021, the Company had accounts payable to Bidi of $12,667,769.
Accounts payable to related paties	$ 12,667,769	1,409,561
Purchased of inventory	15,326,370	6,383
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Purchased of inventory		61,900,000
Chief Financial Officer [Member]
Related Party Transaction [Line Items]
Purchased of inventory		54,000,000
Seven Companies [Member]
Related Party Transaction [Line Items]
Revenues	154,560
Nirajkumar Patel [Member]
Related Party Transaction [Line Items]
Revenue from related parties	233,955
Bidi Vapor [Member]
Related Party Transaction [Line Items]
Due to related party	13,846,950
Bidi [Member]
Related Party Transaction [Line Items]
Purchases of products	53,981,351
Accounts payable to related paties		$ 1,409,561
Favs Business [Member]
Related Party Transaction [Line Items]
Sale of Products	13,900,000
Outstanding balances	$ 1,000
Percentage of accounts receivable	50.00%
M M S Distro [Member]
Related Party Transaction [Line Items]
Sale of Products	$ 9,600,000
C Store Master [Member]
Related Party Transaction [Line Items]
Sale of Products	8,200,000
Outstanding balances	$ 300
Percentage of accounts receivable	16.00%

Income Tax (Details)

Income Tax (Details) - USD ($)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Current Tax Expense:
Federal	$ (1,301,008)	$ 1,249,525
State	(134,190)	265,256
Total Current Tax Expense	(1,435,198)	1,514,781
Deferred Tax Expense:
Federal
State
Total Deferred Tax Expense
Estimated Tax Payments:
Federal
State		182,925
Total Estimated Tax Payment		182,925
Net Income Tax Liability/(Benefit)	$ (1,435,198)	$ 1,331,856

Income Tax (Details 1)

Income Tax (Details 1) - USD ($)	Oct. 31, 2021	Oct. 31, 2020
Deferred Tax Assets:
Stock Compensation Expense – NQSO	$ 384,540
Other	30,099
Net Operating Loss Carryforwards	910,685
Total Deferred Tax Asset	1,325,324
Deferred Tax Liabilities:
Prepaid Expenses	(69,265)
Total Deferred Tax Liabilities	(69,265)
Less: Valuation Allowance	(1,256,059)
Net Deferred Tax Asset

Income Tax (Details Narrative)

Income Tax (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Operating Loss Carryforwards [Line Items]
U.S. federal and state income tax rate	21.00%	35.00%
Statutory corporate income tax rate	4.458%
Income (loss) before income taxes provision	$ (10,468,636)	$ 5,360,603
Valuation allowance	1,256,059
Net operating loss carryforward	1,753,594
Accrued of state income tax	82,331
Income taxes paid		182,925
Income tax accrual		1,331,856
Federal [Member]
Operating Loss Carryforwards [Line Items]
Income (loss) before income taxes provision	$ 4,000,000
State [Member]
Operating Loss Carryforwards [Line Items]
Income (loss) before income taxes provision		$ 1,800,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 17, 2021	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Stock options granted	41,667
Exercise price per share	$ 28.68
Stock options vested fully	$ 1,139,998
Bonus description		cash bonus award equal to $30,000 for every $25 million in gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board of Directors approved a cash bonus award equal to $20,000 for every $25 million in gross revenues generated by the Company. On May 28, 2020, the Board of Directors also approved an equity bonus award for each of the Chief Executive Officer and the Chief Operating Officer. With respect to the Chief Executive Officer, the Board of Directors approved an award of 90,000 restricted shares of the Company’s Common Stock for every $50 million in accumulated gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board of  Directors approved an award of 75,000 restricted shares of the Company’s Common Stock for every $50 million in accumulated gross revenues generated by the Company
Fair value of bonus shares		$ 165,000
General Compensation		Pursuant to the terms of the amendment, the parties modified the amount of General Compensation (as defined below) to be paid to QuikfillRx. “General Compensation’’ consists of the following: (i) for the Services provided in March 2020, the Company paid QuikfillRx an amount equal to $86,000; (ii) for the Services provided in April 2020, the Company paid QuikfillRx an amount equal to $100,000; (iii) each calendar month commencing May 2020 through October 2020, the Company paid QuikfillRx an amount equal to $125,000 per month for the Services to be performed during such calendar month; (iv) if the parties agree to extend the term of the Amended Service Agreement beyond the original expiration date of October 31, 2020, then for the period between November 1, 2020 and October 31, 2021, the Company will pay QuikfillRx $125,000 per month for the Services to be performed during such calendar month; and (iv) if the parties agree to extend the term of the Amended Service Agreement beyond October 31, 2021, then for the period between November 1, 2021 and October 31, 2022, the Company will pay QuikfillRx $150,000 per month for the Services to be performed during such calendar month
Purchase Price		$ 79,592
Acquired quqrterly bonus		$ 3,775

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($)	Nov. 11, 2021	Apr. 22, 2022
Subsequent Event [Line Items]
Restricted common stock issued	61,250
Shares issued withheld	23,243
Cash settlement	$ 124,612
Consulting Agreement [Member] | Inflection Partners [Member]
Subsequent Event [Line Items]
Services description		Company engaged Oakhill Europe to provide strategic advising and negotiation assistance for potential international distribution agreements (collectively, the “Oakhill Services”), in exchange for a $15,000 monthly retainer, incentive compensation bonuses of up to $175,000, and an incentive compensation bonus value of $75,000 paid in fully-vested non-qualified stock options, upon the achievement of certain events